Analytical Data
-
Gene name
PLXDC2
- Application
-
Alternative Names
PLXDC2；TEM7R；Plexin domain-containing Protein 2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6UX71
-
Expression Region
31-454aa
-
AA Sequence
KPGDQILDWQYGVTQAFPHTEEEVEVDSHAYSHRWKRNLDFLKAVDTNRASVGQDSPEPRSFTDLLLDDGQDNNTQIEEDTDHNYYISRIYGPSDSASRDLWVNIDQMEKDKVKIHGILSNTHRQAARVNLSFDFPFYGHFLREITVATGGFIYTGEVVHRMLTATQYIAPLMANFDPSVSRNSTVRYFDNGTALVVQWDHVHLQDNYNLGSFTFQATLLMDGRIIFGYKEIPVLVTQISSTNHPVKVGLSDAFVVVHRIQQIPNVRRRTIYEYHRVELQMSKITNISAVEMTPLPTCLQFNRCGPCVSSQIGFNCSWCSKLQRCSSGFDRHRQDWVDSGCPEESKEKMCENTEPVETSSRTTTTVGATTTQFRVLTTTRRAVTSQFPTSLPTEDDTKIALHLKDNGASTDDSAAEKKGGTLHA
-
Molecular Weight
55.5kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PLXDC2 (Plexin Domain Containing 2) is a member of the Plexin family of proteins, which are known for their roles in axon guidance and cellular signaling pathways. Emerging evidence suggests that PLXDC2 is involved in various physiological processes, including immune response modulation and tumor progression. Its expression has been observed in several cancer types, pointing to its potential role in tumor biology and metastasis. Recent studies have highlighted the importance of understanding the molecular mechanisms through which PLXDC2 influences cell behavior, particularly its interactions with the cytoskeleton and other signaling molecules. This makes PLXDC2 a promising target for therapeutic interventions in cancer and other diseases. The research surrounding recombinant PLXDC2 protein focuses on its structural and functional characterization, enabling scientists to elucidate its biological roles in detail. By producing and studying this recombinant protein, researchers aim to investigate its effects on cell migration, adhesion, and signaling pathways, ultimately contributing to the development of targeted therapies that could disrupt its detrimental roles in pathological conditions. Overall, PLXDC2 represents a fascinating avenue of inquiry with significant implications for understanding cell dynamics and improving treatment strategies in malignancies and immune-related disorders.
